NICO Resources Ltd (NC1N) News

10x Genomics Begins Commercial Shipments of Xenium Prime 5K Pan-Tissue and Pathways Panel

10x Genomics Begins Commercial Shipments of Xenium Prime 5K Pan-Tissue and Pathways Panel PR...

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 4 - Statement of changes in beneficial ownership of securities

10x Genomics Launches 5,000-Plex Gene Panel for Xenium

10x Genomics Launches 5,000-Plex Gene Panel for Xenium PR Newswire PLEASANTON, Calif., May 29, 2024  New...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

10x Genomics to Present at the BofA Securities 2024 Healthcare Conference

10x Genomics to Present at the BofA Securities 2024 Healthcare Conference PR Newswire PLEASANTON, Calif., May...

10x Genomics Reports First Quarter 2024 Financial Results

10x Genomics Reports First Quarter 2024 Financial Results PR Newswire PLEASANTON, Calif., April 30, 2024...

10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024

10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024 PR Newswire PLEASANTON, Calif...

10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay

10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay PR Newswire PLEASANTON, Calif...